High Dose Chemotherapy (HDCT) and Autologous Stem Cell Transplant (ASCT) in Childhood Cancer-Experience from the Royal Marsden Hospital

被引：0
|
作者：
Moulik, N. Roy [1 ]
Indranee, J. [1 ]
Petterson, T. [1 ]
Vaidya, S. [1 ]
机构：
[1] Royal Marsden Hosp, Paediat Oncol, Greater London, England
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-117
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [31] Continuous infusional chemotherapy for early breast cancer: The Royal Marsden Hospital experience
    Smith, IE
    ADJUVANT THERAPY OF PRIMARY BREAST CANCER VI, 1998, 152 : 323 - 327
  • [32] Cost analysis of high dose chemotherapy and autologous stem cell transplantation (HDT/ASCT) in Greece
    Thanopoulou, I.
    Angelopoulou, M.
    Anargyrou, K.
    Tsirkinidis, P.
    Moschogiannis, M.
    Chatzileonida, E.
    Vassilakopoulos, T. P.
    Yakoumis, X.
    Konstadoulakis, K.
    Rombos, Y.
    Vaiopoulos, G.
    Polyzos, N.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 434 - 435
  • [33] High-dose chemotherapy plus autologous stem cell transplation (HDCT/SCT) in patients with sarcoma: A single institution experience.
    Stradella, A.
    Lopez-Pousa, A.
    Quintana, M. J.
    Murata, P.
    Ortin, M.
    Gallego, O.
    Sullivan, I.
    Robert, L.
    Sebio, A.
    Gracia, I.
    De Vega, J. M.
    Barnadas, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Treatment outcomes in multiple sclerosis (MS) patients after early, conventional and salvage high dose chemotherapy (HDCT) plus autologous stem cell transplantation (ASCT).
    Shevchenko, YL
    Novik, AA
    Afanasiev, BV
    Lisukov, IA
    Ionova, TI
    Kulagin, AD
    Malysheva, OA
    Bisaga, GN
    Melnichenko, VJ
    Voloshin, SV
    Fedorenko, DA
    Vereschagina, IV
    Kishtovich, AV
    Fedotov, YN
    Gorodokin, GI
    BLOOD, 2005, 106 (11) : 454B - 454B
  • [35] Single institution experience with two high-dose chemotherapy (HDC) conditioning regimens prior to autologous stem cell transplant (ASCT) for multiple myeloma (MM)
    Benson, DM
    Elder, PJ
    Lin, T
    Blum, W
    Penza, S
    Avalos, B
    Byrd, JC
    Copelan, E
    Farag, SS
    BLOOD, 2004, 104 (11) : 388B - 389B
  • [36] Oxidative Stress Following High Dose Chemotherapy with Autologous Stem Cell Transplant
    Saeed, Hayder
    Alstott, Michael C.
    Mitov, Mihail
    Butterfield, D. Allan
    Dressler, Emily Van Meter
    Yalamanchi, Swati
    Hayslip, John
    Monohan, Gregory
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S131 - S132
  • [37] Social Outcomes after High Dose Chemotherapy with Autologous Stem Cell Transplant
    Arboe, Bente
    Goerloev, Jette Soenderskov
    Olsen, Maja Halgren
    Dalton, Susanne Oksbjerg
    Nielsen, Kristina Fruerlund
    Nielsen, Soeren Ramme
    Madsen, Charlotte
    Nielsen, Rasmus
    Brown, Peter de Nully
    BLOOD, 2016, 128 (22)
  • [38] HIGH DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA
    Ali, N.
    Shaikh, M. U.
    Adil, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5627 - 5627
  • [39] HIGH-DOSE CHEMOTHERAPY (HDCT) AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN GERM CELL TUMORS: THE GITMO/IGG NETWORK
    Rosti, G.
    De Giorgi, U.
    Pedrazzoli, P.
    Salvioni, R.
    ANNALS OF ONCOLOGY, 2009, 20
  • [40] Epoetin alfa administered prior to high-dose chemotherapy (HDCT) and autologous stem-cell rescue
    Henry, D
    Mason, BA
    Staddon, AP
    Ford, PA
    Matthews, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S296 - S296
12345